ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 728979 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 728979; 2) Community: the network communities that were significantly associated with the response to NSC 728979; 3) Molecule: the relationships between components within communities and NSC 728979; 4) MDR: the compounds that were significantly associated with the NSC 728979.

NSC Compound Enrichment Correlation
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.0152653588725063 0.1916602
NSC 9706 Triethylenemelamine 0.0152653588725063 0.62782777
NSC 112758 Rubomycin 0.0152653588725064 0.35965959
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0152653588725064 0.53641158
NSC 134725 K-33 0.0152653588725064 0.55115139
NSC 143147 Urea, 1,1'-(methylenedi-4,1-cyclohexylene)bis[3-(2-chloroethyl)-3-nitroso- (8CI) 0.0152653588725064 0.33957414
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0152653588725064 0.28134163
NSC 282159 EN 589 0.0152653588725064 0.15607131
NSC 343499 CI-921: amsacrine derivative 0.0152653588725064 0.5629737
NSC 49488 Null 0.0152653588725064 0.24850952
Total:100  Current:33    [First] [Prev] [Next] [Last]